drugset / Trial / NCT00988598

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

NCT00988598

Phase 1 Completed 15 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate the safety of PF-04447943 when given in combination with donepezil in subjects who have Alzheimer's Disease. The study will also evaluate the absorption and distribution of both PF-04447943 and donepezil.

Timeline

Start
2009-10-26
Primary completion
2010-07-05
Completion
2010-07-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator EDELINONTRINE Small molecule 25 mg Oral

Indications